0001161697-19-000510.txt : 20191204
0001161697-19-000510.hdr.sgml : 20191204
20191204171644
ACCESSION NUMBER: 0001161697-19-000510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191202
FILED AS OF DATE: 20191204
DATE AS OF CHANGE: 20191204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANDE ALICIA
CENTRAL INDEX KEY: 0001402652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 191268845
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 12-02-2019
X0306
4
2019-12-02
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402652
GRANDE ALICIA
355 ALHAMBRA CIRCLE, SUITE 1250
CORAL GABLES
FL
33134
0
1
0
0
VP, Treasurer and CFO
Options to purchase common stock
4.64
2019-12-02
4
A
0
132000
0
A
2026-12-02
Common Stock
132000
1212000
D
Restricted Stock Units
2019-12-02
4
A
0
44000
0
A
Common Stock
44000
1256000
D
Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares of common stock will be delivered to the Reporting Person upon vesting.
/s/ Alicia Grande
2019-12-04